During the past grant cycle, the Masonic Cancer Center (MCC) used developmental funds to support the following activities: ? 13 newly recruited investigators ? Pilot Projects: several MCC pilot mechanisms provide funding to aid in the development of multi-investigator research.
The aim i s to develop competitive applications to submit to the National Cancer Institute's Specialized Programs of Research Excellence (SPOREs), Program Project (P01), or similar grant programs ? Clinical Pharmacology Developing Shared Resource, which has become an established shared resource in this submission ? Translational Methodologies support enabled Dr. Gunda Georg, Director of the Institute for Therapeutics Discovery &Development, to generate a triptolide derivative (termed Minnelide) and to optimize its pharmacokinetic properties for use as a cancer therapeutic. Recent work demonstrated the efficacy of this drug in vivo. Minnelide has been licensed to Minneamrita Therapeutics LLC for production and will be in a clinical phase I trial in the first half of 2013 The MCC is proposing to use developmental funds for the following purposes in the upcoming funding period: ? Newly recruited faculty ? Pilot research ? Two developing shared resources o Recruitment and Retention: This shared resource will support investigators in developing recruitment plans for therapeutic and non-therapeutic studies and ensuring complete and timely enrollment of participants. o Genome Engineering: This shared resource will use recombinant adeno-associated virus (rAAV) and transcription activator-like effector nucleases (TALENs) to make site-specific alterations in human cell lines ofthe investigator's choosing. ? Staff Investigator: We are requesting funding for a 10% time Research Staff Investigator who will be responsible for developing the Cancer Detection, Treatment, and Survivorship (CaDeTS) component of the Prevention and Etiology Program to address a range of issues relevant to cancer patients and their families, including early detection through screening programs, comparative effectiveness and quality of cancer care across the continuum of care, and long-term quality-of-life outcomes of cancer survivors

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA077598-16
Application #
8633140
Study Section
Subcommittee G - Education (NCI)
Project Start
1998-06-01
Project End
2019-01-31
Budget Start
2014-03-05
Budget End
2015-01-31
Support Year
16
Fiscal Year
2014
Total Cost
$305,549
Indirect Cost
$61,605
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Abbott, Kenneth L; Nyre, Erik T; Abrahante, Juan et al. (2015) The Candidate Cancer Gene Database: a database of cancer driver genes from forward genetic screens in mice. Nucleic Acids Res 43:D844-8
Yee, Douglas (2015) A tale of two receptors: insulin and insulin-like growth factor signaling in cancer. Clin Cancer Res 21:667-9
Daniel, A R; Gaviglio, A L; Knutson, T P et al. (2015) Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes. Oncogene 34:506-15
Upadhyaya, Pramod; Hecht, Stephen S (2015) Quantitative analysis of 3'-hydroxynorcotinine in human urine. Nicotine Tob Res 17:524-9
Patel, Yesha M; Stram, Daniel O; Wilkens, Lynne R et al. (2015) The contribution of common genetic variation to nicotine and cotinine glucuronidation in multiple ethnic/racial populations. Cancer Epidemiol Biomarkers Prev 24:119-27
Cooley, Sarah; Weisdorf, Daniel J; Guethlein, Lisbeth A et al. (2014) Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia. J Immunol 192:4592-600
Chen, Liddy M; Ibrahim, Joseph G; Chu, Haitao (2014) Flexible stopping boundaries when changing primary endpoints after unblinded interim analyses. J Biopharm Stat 24:817-33
Takahashi, Yutaka; Hui, Susanta K (2014) Fast, simple, and informative patient-specific dose verification method for intensity modulated total marrow irradiation with helical tomotherapy. Radiat Oncol 9:34
Gates, Leah A; Phillips, Martin B; Matter, Brock A et al. (2014) Comparative metabolism of furan in rodent and human cryopreserved hepatocytes. Drug Metab Dispos 42:1132-6
Gorden, Brandi H; Kim, Jong-Hyuk; Sarver, Aaron L et al. (2014) Identification of three molecular and functional subtypes in canine hemangiosarcoma through gene expression profiling and progenitor cell characterization. Am J Pathol 184:985-95

Showing the most recent 10 out of 319 publications